CRYOPORT, INC. Foreign Currency Transaction Gain (Loss), before Tax
CRYOPORT, INC. (CYRX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$600.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-06
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $200.00K, a 97.70% decline year-over-year.
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$800.00K, a 122.86% decline year-over-year.
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $300.00K.
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was $400.00K, a 86.67% decline year-over-year.
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for fiscal 2025 was $12.90M.
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for fiscal 2024 was -$4.30M.
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for fiscal 2023 was -$1.30M.
- CRYOPORT, INC. foreign currency transaction gain (loss), before tax for fiscal 2022 was -$9.80M.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $200.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$600.00K 10-Q · filed 2026-08-06 | -$300.00K derived: sum of 3 quarters · filed 2026-08-06 | $100.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$800.00K 10-Q · filed 2026-05-05 | -$500.00K derived: sum of 2 quarters · filed 2026-05-05 | -$100.00K derived: sum of 3 quarters · filed 2026-05-05 | $8.60M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $700.00K derived: sum of 2 quarters · filed 2026-03-05 | $9.40M derived: sum of 3 quarters · filed 2026-08-06 | $12.90M 10-K · filed 2026-03-05 | ||||
| 2025-09-30 | $400.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $9.10M derived: sum of 2 quarters · filed 2026-08-06 | $12.60M 10-Q · filed 2025-11-06 | $8.10M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $8.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $12.20M 10-Q · filed 2026-08-06 | $7.70M derived: sum of 3 quarters · filed 2026-08-06 | $10.70M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $3.50M 10-Q · filed 2026-05-05 | -$1.00M derived: sum of 2 quarters · filed 2026-05-05 | $2.00M derived: sum of 3 quarters · filed 2026-05-05 | $1.20M derived: sum of 4 quarters · filed 2026-05-05 | ||||
| 2024-12-31 | -$4.50M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$1.50M derived: sum of 2 quarters · filed 2026-03-05 | -$2.30M derived: sum of 3 quarters · filed 2026-03-05 | -$4.30M 10-K · filed 2026-03-05 | ||||
| 2024-09-30 | $3.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.20M derived: sum of 2 quarters · filed 2025-11-06 | $200.00K 10-Q · filed 2025-11-06 | $2.90M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-06-30 | -$800.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$2.80M 10-Q · filed 2025-08-12 | -$100.00K derived: sum of 3 quarters · filed 2026-03-05 | -$1.10M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2024-03-31 | -$2.00M 10-Q · filed 2025-05-08 | $700.00K derived: sum of 2 quarters · filed 2026-03-05 | -$300.00K derived: sum of 3 quarters · filed 2026-03-05 | -$4.50M derived: sum of 4 quarters · filed 2026-03-05 | ||||
| 2023-12-31 | $2.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.70M derived: sum of 2 quarters · filed 2026-03-05 | -$2.50M derived: sum of 3 quarters · filed 2026-03-05 | -$1.30M 10-K · filed 2026-03-05 | ||||
| 2023-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | -$5.20M derived: sum of 2 quarters · filed 2024-11-07 | -$4.00M 10-Q · filed 2024-11-07 | $2.00M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2023-06-30 | -$4.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$3.00M 10-Q · filed 2024-08-08 | $3.00M 10-Q · filed 2023-08-09 | $3.00M derived: sum of 3 quarters · filed 2025-03-07 | -$21.40M derived: sum of 4 quarters · filed 2025-03-07 | |||
| 2023-03-31 | $1.20M 10-Q · filed 2024-05-08 | $7.20M derived: sum of 2 quarters · filed 2025-03-07 | -$17.20M derived: sum of 3 quarters · filed 2025-03-07 | -$7.50M derived: sum of 4 quarters · filed 2025-03-07 | ||||
| 2022-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | -$18.40M derived: sum of 2 quarters · filed 2025-03-07 | -$8.70M derived: sum of 3 quarters · filed 2025-03-07 | -$9.80M 10-K · filed 2025-03-07 | ||||
| 2022-09-30 | -$24.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$14.70M derived: sum of 2 quarters · filed 2023-11-09 | -$15.80M 10-Q · filed 2023-11-09 | -$14.80M derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2022-06-30 | $9.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $8.60M 10-Q · filed 2023-08-09 | -$8.60M 10-Q · filed 2022-08-04 | $9.60M derived: sum of 3 quarters · filed 2024-03-13 | $9.10M derived: sum of 4 quarters · filed 2024-03-13 | |||
| 2022-03-31 | -$1.10M 10-Q · filed 2023-05-04 | -$100.00K derived: sum of 2 quarters · filed 2024-03-13 | -$600.00K derived: sum of 3 quarters · filed 2024-03-13 | $100.00K derived: sum of 4 quarters · filed 2024-03-13 | ||||
| 2021-12-31 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $500.00K derived: sum of 2 quarters · filed 2024-03-13 | $1.20M derived: sum of 3 quarters · filed 2024-03-13 | -$2.60M 10-K · filed 2024-03-13 | ||||
| 2021-09-30 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $200.00K derived: sum of 2 quarters · filed 2022-11-04 | -$3.60M 10-Q · filed 2022-11-04 | $1.60M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $700.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$3.10M 10-Q · filed 2022-08-04 | $2.10M derived: sum of 3 quarters · filed 2023-02-28 | $2.12M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | -$3.80M 10-Q · filed 2022-05-05 | $1.40M derived: sum of 2 quarters · filed 2023-02-28 | $1.42M derived: sum of 3 quarters · filed 2023-02-28 | $1.42M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $5.20M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $5.22M derived: sum of 2 quarters · filed 2023-02-28 | $5.22M derived: sum of 3 quarters · filed 2023-02-28 | $5.20M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $23.80K 10-Q · filed 2020-11-06 | $21.00K derived: sum of 2 quarters · filed 2020-11-06 | $0.00 10-Q · filed 2021-11-04 | $19.80K 10-Q · filed 2020-11-06 | $52.00K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-06-30 | -$2.80K 10-Q · filed 2020-08-10 | $0.00 10-Q · filed 2021-08-06 | -$3.90K 10-Q · filed 2020-08-10 | $28.20K derived: sum of 3 quarters · filed 2022-02-28 | $8.90K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-06 | -$2.27K 10-Q · filed 2020-05-08 | $31.00K derived: sum of 2 quarters · filed 2022-02-28 | $11.70K derived: sum of 3 quarters · filed 2022-02-28 | $10.20K derived: sum of 4 quarters · filed 2022-02-28 | |||
| 2019-12-31 | $31.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $11.70K derived: sum of 2 quarters · filed 2022-02-28 | $10.20K derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 | $2.90K 10-K · filed 2020-03-10 | |||
| 2019-09-30 | -$19.30K 10-Q · filed 2020-11-06 | -$20.80K derived: sum of 2 quarters · filed 2020-11-06 | -$31.00K 10-Q · filed 2020-11-06 | -$64.23K derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | -$1.50K 10-Q · filed 2020-08-10 | -$11.60K 10-Q · filed 2020-08-10 | -$44.93K derived: sum of 3 quarters · filed 2020-08-10 | -$31.98K derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | -$10.08K 10-Q · filed 2019-05-09 | -$43.43K derived: sum of 2 quarters · filed 2020-03-10 | -$30.48K derived: sum of 3 quarters · filed 2020-03-10 | |||||
| 2018-12-31 | -$33.35K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$20.40K derived: sum of 2 quarters · filed 2020-03-10 | -$20.40K 10-K · filed 2020-03-10 | |||||
| 2018-09-30 | $12.95K 10-Q · filed 2018-11-08 | $12.95K 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |